PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$290.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Elsevier Science Publishing Co Inc
17 February 2022
Diabetic Neuropathy identifies the most accurate early biomarkers of nerve damage to better understand pathophysiology and diagnose diabetic neuropathy in the clinical care of patients, and in particular, permit an accurate evaluation of future therapies in clinical trials. This succinct reference focuses on the current data and research on diabetic neuropathy and is essential reading for researchers in endocrinology, neurology and pharmacology, along with clinicians that need to better understand the novel pathogenetic pathways leading to diabetic neuropathy and the treatments.

By:  
Edited by:  
Imprint:   Elsevier Science Publishing Co Inc
Country of Publication:   United States
Dimensions:   Height: 276mm,  Width: 216mm, 
Weight:   860g
ISBN:   9780128206690
ISBN 10:   0128206691
Pages:   398
Publication Date:  
Audience:   Professional and scholarly ,  College/higher education ,  Undergraduate ,  Further / Higher Education
Format:   Paperback
Publisher's Status:   Active

Professor Mitra Tavakoli is Associate Professor of Medicine at the University of Exeter and is distinguished for her significant contribution to our understanding of the small fibre neuropathy at diabetes and establishing the technique of “Corneal Confocal Microscopy”. She is an internationally recognised researcher in diabetes care, with a significant focus on innovation and bringing new ideas to the field. Her recent work elucidated the role of intervention for the regeneration of nerves at type 1 and type 2 diabetes. Her ongoing research into understanding the role of novel intervention at rare models of neuropathies, which initiated a new direction of research. Dr Tavakoli has been the lead investigator in several national and international multisite clinical trials and a Chief Investigator in major clinical trials. Her research is funded mainly by Industry, National Institute of Health Research (NIHR), National Institute of Health (NIH). She has published over 75 peer-reviewed scientific papers and textbook chapters and in excess of 100 abstracts. She regularly speaks at international and national conferences and meetings. In addition, she is widely respected for training scientists across the world. She spearheads new technologies and contributes to the major UK and international collaborations.

See Also